Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Metamorphopsia
ADR ID BADD_A06174
ADR Hierarchy
06      Eye disorders
06.02      Vision disorders
06.02.06      Visual disorders NEC
06.02.06.014      Metamorphopsia
17      Nervous system disorders
17.17      Neurological disorders of the eye
17.17.01      Neurologic visual problems NEC
17.17.01.020      Metamorphopsia
Description Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132). | Limitation in visual functions. [MeSH]
MedDRA Code 10063341
MeSH ID D014786
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Metamorphopsia | Distorted vision | Vision Disorders | Vision Disorder | Visual Disorders | Disorder, Visual | Disorders, Visual | Visual Disorder | Macropsia | Macropsias | Visual Impairment | Impairment, Visual | Impairments, Visual | Visual Impairments | Micropsia | Micropsias | Vision Disability | Disabilities, Vision | Disability, Vision | Vision Disabilities | Hemeralopia | Hemeralopias | Day Blindness | Blindness, Day | Metamorphopsias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00981Gabapentin0.000041%
BADD_D01251Latanoprost0.000202%
BADD_D01281Levonorgestrel0.000709%
BADD_D01285Levothyroxine0.000011%
BADD_D01290Lifitegrast0.002043%
BADD_D01496Montelukast0.000066%
BADD_D01594Ocriplasmin--
BADD_D01771Pilocarpine hydrochloride0.005051%
BADD_D01834Prednisone0.000018%
BADD_D01835Pregabalin0.000052%
BADD_D02010Sertraline0.000013%
BADD_D02247Topiramate0.000101%
BADD_D02257Trametinib0.000112%
BADD_D02355Vigabatrin0.000336%
BADD_D02369Voriconazole0.011617%
BADD_D02464Fingolimod0.002845%
BADD_D02488Esketamine0.000315%
The 1th Page    1    Total 1 Pages